Tuberculosis and Respiratory Diseases

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma

Jong Hyun Choi, Juwhan Choi, Sang Mi Chung, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Hyun Kyung Lee, Sung Yong Lee

Tuberc Respir Dis. 2019;82(3):211-216. Published online December 20, 2018
DOI: https://doi.org/10.4046/trd.2018.0019

The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma

Jong Hyun Choi, Juwhan Choi, Sang Mi Chung, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Hyun Kyung Lee, Sung Yong Lee

Tuberculosis and Respiratory Diseases. 2019;82(3):211

Link1 Link2 Link3

Weekly docetaxel as first-line therapy for elderly patients with advanced non-small cell lung cancer (NSCLC)

J.D Hainsworth, H.A Burris, L.H Morrissey, S Litchy, F.A Greco

Lung Cancer. 2000;29(1):63

Link1 Link2

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes

Vera Hirsh, Amy Ko, Richard Pilot, Markus F. Renschler, Mark A. Socinski

Clinical Lung Cancer. 2016;17(5):367-374

Link1 Link2

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment

Corey J. Langer, Vera Hirsh, Amy Ko, Markus F. Renschler, Mark A. Socinski

Clinical Lung Cancer. 2015;16(2):112-120

Link1 Link2

Weekly combination chemotherapy with docetaxel and gemcitabine as first-line treatment for elderly patients and patients with poor performance status who have extensive-stage small cell lung carcinoma

John D. Hainsworth, Donna Carrell, Ronald L. Drengler, Carroll Scroggin, F. Anthony Greco

Cancer. 2004;100(11):2437-2441

Link1 Link2

A retrospective analysis of safety and efficacy of weekly nab-paclitaxel as second-line chemotherapy in elderly patients with advanced squamous non-small-cell lung carcinoma

Jinming Yu, Feng Jin, Hui Zhu, Fang Shi, Li Kong

Clinical Interventions in Aging. 2016;167

Link1

P2.01-035 Phase II Study: Weekly Docetaxel as First Line Chemotherapy for Elderly Patients with Squamous-Cell Non-Small-Cell Lung Cancer

S.Y. Lee, J.H. Choi, S.M. Chung, J.Y. Oh, Y.S. Lee, K.H. Min, G.Y. Hur, J.J. Shim, K.H. Kang, H.K. Lee

Journal of Thoracic Oncology. 2017;12(11):S2082

Link1 Link2

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Filippo de Marinis

Therapeutics and Clinical Risk Management. 2009;781

Link1

First-line osimertinib treatment in patients with lung squamous cell carcinoma harboring active epidermal growth factor receptor mutations

Satoshi Shoji, Satoshi Watanabe, Kaori Takamura, Hajime Umezu, Toshiaki Kikuchi

Lung Cancer. 2020;140:113-115

Link1 Link2

A phase II study using teniposide (VM26) alone as first line therapy in elderly patients (PTS) affected by Small Cell Lung Cancer (SCLC)

Lung Cancer. 1991;7:142

Link1 Link2